logo
welcome
Reuters

Reuters

US FDA says two more doses of Novo Nordisk's weight-loss drug now available

Reuters
Summary
Nutrition label

80% Informative

Two more doses of Novo Nordisk's weight-loss drug, Wegovy , is now available on the U.S. Food and Drug Administration's updated shortages list.

GLP-1 therapies have shown to reduce weight by up to 20% in trials.

Some analysts estimate that the market for these therapies could hit $150 billion in revenues by 2030s .

VR Score

88

Informative language

93

Neutral language

77

Article tone

formal

Language

English

Language complexity

56

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links